Risks and benefits of gene therapy and transplantation in sickle cell disease. Comment on: ,HLA-haploidentical hematopoietic stem cell transplantation in patients with sickle cell disease: results from the phase II DREP-HAPLO trial-

Authors

Institutions

Publication Details

Journal
Haematologica
Published
2026-07-23
DOI
https://doi.org/10.3324/haematol.2026.301370
Primary Topic
Hemoglobinopathies and Related Disorders
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Risks and benefits of gene therapy and transplantation in sickle cell disease. Comment on: ,HLA-haploidentical hematopoietic stem cell transplantation in patients with sickle cell disease: results from the phase II DREP-HAPLO trial-

Haydar Frangoul, Mariane De Montalembert
Haematologica
Hemoglobinopathies and Related Disorders
article

Risks and benefits of gene therapy and transplantation in sickle cell disease. Comment on: ,HLA-haploidentical hematopoietic stem cell transplantation in patients with sickle cell disease: results from the phase II DREP-HAPLO trial-

Haydar Frangoul, Mariane De Montalembert
article en

Abstract

No abstract available for this paper.
Haematologica
Inserm (FR), Assistance Publique – Hôpitaux de Paris (FR), Children’s Hospital at TriStar Centennial (US)
Vertex Pharmaceuticals, Jazz Pharmaceuticals
Good health and well-being
Openalex Percentile: Top 10%
Hemoglobinopathies and Related Disorders
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.